Coulee Medical Center Critical Access Hospital (Medicare Certified) Location: 411 Fortuyn Road, Grand Coulee, Washington 99133 Ratings: Phone: (509) 633-1753 |
News Archive
A biotechnology startup enabled by UC Davis, Molecular Matrix Inc., has received Food and Drug Administration clearance for a carbohydrate-based polymer that can help injured bones heal and regrow.
A group of scientists have just made a key discovery that could prevent and eradicate immune responses that lead to treatment failure in about one-third of people with severe hemophilia A.
Associate Professor Menglin Chen has received a major grant from the Carlsberg Foundation to develop a completely new method of regenerating brain and heart cells.
Both medication and psychotherapy are effective in obsessive-compulsive disorder (OCD). However, they both have disadvantages. A group of researchers at the La Sapienza University studied the long-term effectiveness of integrated treatment compared with medication alone.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin (TTR) gene for the treatment of TTR-mediated amyloidosis (ATTR). The study is aimed at evaluating the safety and tolerability of ALN-TTR02 in healthy volunteers.
› Verified 7 days ago